Issue : The Pharmaceutical Journal, online
Sort by: Newest first Oldest first A-Z Z-A
-
Two new members join Scottish Pharmacy Board
Two new members have joined the Royal Pharmaceutical Society’s Scottish Pharmacy Board.
-
Blurring of lines between medicines and medical devices is confusing authorisation process, MHRA warns Subscription
Gaps in the medicine authorisation regulatory system are emerging as the line between medicines and medical devices becomes increasingly blurred.
-
Pharmacists face continued EpiPen shortages Subscription
Pharmacists in the UK are having to ration stocks of EpiPen, a first-line treatment for anaphylaxis, as a result of ongoing shortages.
-
Pharmacy sector calls for moratorium on FMD sanctions at implementation Subscription
The pharmacy sector should be given a “period of grace” on sanctions after the Falsified Medicines Directive implementation date to allow for the new processes and procedures to be embedded in daily routines, the Royal Pharmaceutical Society has said.
-
Fewer medicines at risk of supply disruption after Brexit as companies take action
The number of centrally authorised medicines that could have had their supply disrupted after Brexit has fallen from 108 to 39, according to the European Medicines Agency.
-
PSNC and NPA brief NHS England on role of pharmacy in ten-year plan Subscription
The Pharmaceutical Services Negotiating Committee and the National Pharmacy Association have submitted three briefing documents to NHS England to highlight how community pharmacy could help meet specific challenges that the NHS is trying to address in its ten-year plan.
-
Legal ruling on off-label drug use could save NHS money Subscription
A landmark ruling on treatment for wet age-related macular degeneration that could save the NHS millions of pounds has been welcomed by healthcare leaders and clinicians.
-
New antibiotic and migraine drug among 13 medicines recommended by EMA
The European Medicines Agency has recommended 13 medicines for approval, including three orphan medicines.
-
RPS sets out tests for primary care networks Subscription
The Royal Pharmaceutical Society has written to NHS England calling for community pharmacists to play a role in primary care leadership and for medicines optimisation advocates to be involved in local leadership.
-
Robbie Turner: 'The RPS is here to put pharmacy at the forefront of healthcare'
After 18 months as the Royal Pharmaceutical Society’s (RPS) director for England, Robbie Turner has taken on the new role of director for pharmacy and member experience. Here, he explains what his new directorship is about and how the RPS is adapting for the future.
Show 10 per page20 per page50 per page
